Reuters logo
BRIEF-Immunovaccine announces positive phase 1 topline data for DepoVax-based respiratory syncytial virus vaccine candidate
October 13, 2016 / 11:21 AM / a year ago

BRIEF-Immunovaccine announces positive phase 1 topline data for DepoVax-based respiratory syncytial virus vaccine candidate

Oct 13 (Reuters) - Immunovaccine Inc :

* Immunovaccine announces positive phase 1 topline data for depovax(tm)-based respiratory syncytial virus vaccine candidate

* Immunovaccine Inc - vaccine had a positive safety profile and was well tolerated with no serious adverse events among all study participants Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below